Skip to main content
Top
Published in: Infection 6/2018

01-12-2018 | Case Report

Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection

Authors: Lena M. Biehl, Rebeca Cruz Aguilar, Fedja Farowski, Werner Hahn, Angela Nowag, Hilmar Wisplinghoff, Maria J. G. T. Vehreschild

Published in: Infection | Issue 6/2018

Login to get access

Abstract

Purpose

We report on a kidney transplant recipient treated with fecal microbiota transplantation (FMT) for recurrent urinary tract infections.

Methods

FMT was administered via frozen capsulized microbiota. Before and after FMT, urinary, fecal and vaginal microbiota compositions were analyzed.

Results

The patient remained without symptoms after FMT.

Conclusions

Underlying mechanisms of action need to be addressed in depth by future research.
Literature
1.
go back to reference Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259–68.CrossRef Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259–68.CrossRef
8.
go back to reference R Core Team. R: a language and environment for statistical computing. 3.2.5 ed. Vienna: R Foundation for Statistical Computing; 2016. R Core Team. R: a language and environment for statistical computing. 3.2.5 ed. Vienna: R Foundation for Statistical Computing; 2016.
Metadata
Title
Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection
Authors
Lena M. Biehl
Rebeca Cruz Aguilar
Fedja Farowski
Werner Hahn
Angela Nowag
Hilmar Wisplinghoff
Maria J. G. T. Vehreschild
Publication date
01-12-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1190-9

Other articles of this Issue 6/2018

Infection 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.